The Hypoxia-regulated Ectonucleotidase CD73 is a Host Determinant of HIV Latency

Deciphering the mechanisms underlying viral persistence is critical to achieving a cure for HIV infection. We uncovered molecular signatures of HIV latently-infected CD4+ T cells, identifying the adenosine-producing ectonucleotidase CD73 as a key marker of latent infection. Hypoxic conditioning, reflective of tissue microenvironments, increased the frequency of CD73+ CD4+ T cells and promoted HIV latency. Transcriptomic profiles of CD73+ CD4+ T cells indicated expression phenotypes favoring viral persistence, immune evasion, and cell survival. Further, we demonstrate that CD73+ CD4+ T cells harbor a functional HIV reservoir and are capable of reinitiating productive infection in vitro. Moreover, blocking of the A2A receptor facilitates HIV reactivation in vitro, linking adenosine signaling to viral quiescence. Finally, tissue imaging of lymph nodes from HIV-infected individuals on antiretroviral therapy reveal spatial association between CD73 expression and HIV persistence in vivo. Our findings warrant exploration of the hypoxia-CD73-adenosine axis in curative strategies to promote viral eradication.

[1]  Xinyue Wang,et al.  Decreased CD73+ Double-Negative T Cells and Elevated Level of Soluble CD73 Correlated With and Predicted Poor Immune Reconstitution in HIV-Infected Patients After Antiretroviral Therapy , 2022, Frontiers in Immunology.

[2]  Jiyuan Zhang,et al.  Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways , 2021, Frontiers in Immunology.

[3]  W. Greene,et al.  Characterization of HIV-induced remodeling reveals differences in infection susceptibility of memory CD4+ T cell subsets in vivo , 2021, Cell reports.

[4]  W. Greene,et al.  Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir , 2020, eLife.

[5]  P. Borrow,et al.  Hypoxic microenvironment shapes HIV-1 replication and latency , 2020, Communications Biology.

[6]  L. Buisseret,et al.  The adenosine pathway in immuno-oncology , 2020, Nature Reviews Clinical Oncology.

[7]  L. Giudice,et al.  HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread , 2020, eLife.

[8]  M. Donoso,et al.  Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4+ T cell recovery can harbor replication-competent HIV despite viral suppression , 2020, Science Translational Medicine.

[9]  B. Berkhout,et al.  The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like , 2019, Front. Immunol..

[10]  Rosa M. Badia,et al.  Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab , 2019, Nature Communications.

[11]  Yong Wan,et al.  CD73: an emerging checkpoint for cancer immunotherapy. , 2019, Immunotherapy.

[12]  P. Klenerman,et al.  CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype , 2019, Mucosal Immunology.

[13]  J. McCune,et al.  CD32-RNA Co-localizes with HIV-RNA in CD3+ Cells Found within Gut Tissues from Viremic and ART-Suppressed Individuals , 2019, Pathogens & immunity.

[14]  R. Cheynier,et al.  HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy , 2019, Nature Microbiology.

[15]  J. Sosman,et al.  CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy , 2019, Nature Communications.

[16]  S. Morgello,et al.  Identification, Localization, and Quantification of HIV Reservoirs Using Microscopy , 2018, Current protocols in cell biology.

[17]  D. Allard,et al.  Targeting the CD73-adenosine axis in immuno-oncology. , 2019, Immunology letters.

[18]  L. Kats,et al.  Targeting Adenosine Receptor Signaling in Cancer Immunotherapy , 2018, International journal of molecular sciences.

[19]  R. Apps,et al.  Evidence that CD32a does not mark the HIV-1 latent reservoir , 2018, Nature.

[20]  O. Sued,et al.  Induction of HIF-1α by HIV-1 Infection in CD4+ T Cells Promotes Viral Replication and Drives Extracellular Vesicle-Mediated Inflammation , 2018, mBio.

[21]  R. Apps,et al.  Evidence that CD32a does not mark the HIV-1 latent reservoir , 2018, Nature.

[22]  L. Emens,et al.  Targeting adenosine for cancer immunotherapy , 2018, Journal of Immunotherapy for Cancer.

[23]  R. Gottardo,et al.  CD32+ and PD-1+ Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals , 2018, Journal of Virology.

[24]  P. Klenerman,et al.  CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA , 2018, Front. Immunol..

[25]  S. Eichmüller,et al.  Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E , 2018, Front. Immunol..

[26]  Ghasem Ghalamfarsa,et al.  Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer , 2018, Journal of cellular physiology.

[27]  Emily B Hanhauser,et al.  Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30 , 2018, PLoS pathogens.

[28]  L. Su,et al.  Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4+ T Cells Through Cyclic Adenosine Monophosphate–Dependent Mechanisms in Humanized Mice In Vivo , 2017, The Journal of infectious diseases.

[29]  R. Balderas,et al.  CTLA‐4+PD‐1− Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy‐Suppressed, SIV‐Infected Rhesus Macaques , 2017, Immunity.

[30]  Deborah S. Barkauskas,et al.  Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases , 2017, Oncoimmunology.

[31]  Y. Lévy,et al.  CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses , 2017, Nature.

[32]  L. Zenewicz,et al.  Oxygen Levels and Immunological Studies , 2017, Front. Immunol..

[33]  F. Di Virgilio,et al.  Extracellular purines, purinergic receptors and tumor growth , 2016, Oncogene.

[34]  S. Lewin,et al.  CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART , 2016, PLoS pathogens.

[35]  L. Antonioli,et al.  Anti-CD73 in cancer immunotherapy: awakening new opportunities. , 2016, Trends in cancer.

[36]  C. Rinaldo,et al.  Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues , 2015, Journal of Virology.

[37]  E. Verdin,et al.  HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells , 2015, PLoS pathogens.

[38]  N. Chomont,et al.  HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide? , 2015, Journal of virus eradication.

[39]  Xin Geng,et al.  Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection , 2013, Nature.

[40]  Timothy J. Laurent,et al.  Dual-color HIV reporters trace a population of latently infected cells and enable their purification. , 2013, Virology.

[41]  W. Greene,et al.  Calcium/Calcineurin Synergizes with Prostratin to Promote NF-κB Dependent Activation of Latent HIV , 2013, PloS one.

[42]  Sarah B. Laskey,et al.  Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.

[43]  W. Greene,et al.  An Integrated Overview of HIV-1 Latency , 2013, Cell.

[44]  J. Hauber,et al.  Decreased frequency of CD73+CD8+ T cells of HIV‐infected patients correlates with immune activation and T cell exhaustion , 2013, Journal of leukocyte biology.

[45]  J. Mellors,et al.  CD4+CD73+ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression , 2013, AIDS.

[46]  L. Marchionni,et al.  High Levels of CD2 Expression Identify HIV-1 Latently Infected Resting Memory CD4+ T Cells in Virally Suppressed Subjects , 2013, Journal of Virology.

[47]  E. Vizi,et al.  CD39 and CD73 in immunity and inflammation. , 2013, Trends in molecular medicine.

[48]  A. K. Kondapi,et al.  Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription. , 2013, Archives of biochemistry and biophysics.

[49]  J. Dranoff,et al.  Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase/CD73 via specific SP1 and SMAD promoter elements. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[50]  W. Greene,et al.  A Flexible Model of HIV-1 Latency Permitting Evaluation of Many Primary CD4 T-Cell Reservoirs , 2012, PloS one.

[51]  Bin Zhang CD73 promotes tumor growth and metastasis , 2012, Oncoimmunology.

[52]  K. Khalili,et al.  Regulation of the HIV-1 promoter by HIF-1α and Vpr proteins , 2011, Virology Journal.

[53]  J. Schrader,et al.  Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells. , 2011, American journal of physiology. Cell physiology.

[54]  A. Ohta,et al.  In vivo T Cell Activation in Lymphoid Tissues is Inhibited in the Oxygen-Poor Microenvironment , 2011, Front. Immun..

[55]  O. Delaneau,et al.  CD39/Adenosine Pathway Is Involved in AIDS Progression , 2011, PLoS pathogens.

[56]  C. Kieda,et al.  Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia , 2011, Journal of cellular and molecular medicine.

[57]  Kenneth W Dunn,et al.  A practical guide to evaluating colocalization in biological microscopy. , 2011, American journal of physiology. Cell physiology.

[58]  Bin Zhang CD73: a novel target for cancer immunotherapy. , 2010, Cancer research.

[59]  Sergei Nekhai,et al.  Regulation of HIV‐1 transcription at 3% versus 21% oxygen concentration , 2009, Journal of cellular physiology.

[60]  K. Khalili,et al.  Activation of the Oxidative Stress Pathway by HIV-1 Vpr Leads to Induction of Hypoxia-inducible Factor 1α Expression* , 2009, Journal of Biological Chemistry.

[61]  J Darbyshire,et al.  CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.

[62]  E. Verdin,et al.  HIV reproducibly establishes a latent infection after acute infection of T cells in vitro , 2003, The EMBO journal.

[63]  E. Heist,et al.  Protein Kinase A Negatively Modulates the Nuclear Accumulation of NF-ATc1 by Priming for Subsequent Phosphorylation by Glycogen Synthase Kinase-3* , 2002, The Journal of Biological Chemistry.

[64]  S. Colgan,et al.  Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. , 2002, The Journal of clinical investigation.

[65]  S. Jalkanen,et al.  The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells. , 2002, The Biochemical journal.

[66]  W. Greene,et al.  Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy , 2002, Nature Medicine.

[67]  M. Sitkovsky,et al.  Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions , 2001, The Journal of Immunology.

[68]  R. Siliciano,et al.  Latency and viral persistence in HIV-1 infection. , 2000, The Journal of clinical investigation.

[69]  R. Lempicki,et al.  HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[70]  D. Baltimore,et al.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. , 1999, Immunity.

[71]  J. Lisziewicz,et al.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.

[72]  S. Harrison,et al.  Structure of an IκBα/NF-κB Complex , 1998, Cell.

[73]  H. Saito,et al.  Hematopoietic transcription factor GATA‐2 activates transcription from HIV‐1 long terminal repeat , 1998, AIDS.

[74]  D. Richman,et al.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.

[75]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[76]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[77]  C. Webb,et al.  Isolation and characterization of the promoter of the human 5'-nucleotidase (CD73)-encoding gene. , 1995, Gene.

[78]  Douglas L. Smith,et al.  Any Color You Like , 1994 .

[79]  C. Kneitz,et al.  Mechanism of MHC class I downregulation in HIV infected cells. , 1992, Immunobiology.